Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

Fu D, Li C, Huang Y

OncoTargets and Therapy 2021, 14:2449-2461

Published Date: 9 April 2021